{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T17:22:36Z","timestamp":1775064156707,"version":"3.50.1"},"reference-count":34,"publisher":"American Society for Microbiology","issue":"1","license":[{"start":{"date-parts":[[2019,12,20]],"date-time":"2019-12-20T00:00:00Z","timestamp":1576800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2019,12,20]]},"abstract":"<jats:p>\n            The increasing global prevalence of carbapenem-resistant\n            <jats:italic>Enterobacteriaceae<\/jats:italic>\n            (CRE) combined with the decline in effective therapies is a public health care crisis. After respiratory tract infections, urinary tract infections and associated urosepsis are the second most affected by CRE pathogens.\n          <\/jats:p>","DOI":"10.1128\/aac.01839-19","type":"journal-article","created":{"date-parts":[[2019,10,22]],"date-time":"2019-10-22T10:45:28Z","timestamp":1571741128000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":8,"title":["Carbapenem-Containing Combination Antibiotic Therapy against Carbapenem-Resistant Uropathogenic\n            <i>Enterobacteriaceae<\/i>"],"prefix":"10.1128","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2319-7734","authenticated-orcid":false,"given":"Maria","family":"Loose","sequence":"first","affiliation":[{"name":"Clinic for Urology, Paediatric Urology and Andrology, Justus-Liebig University of Giessen, Giessen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabell","family":"Link","sequence":"additional","affiliation":[{"name":"Clinic for Urology, Paediatric Urology and Andrology, Justus-Liebig University of Giessen, Giessen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kurt G.","family":"Naber","sequence":"additional","affiliation":[{"name":"Technical University of Munich, Munich, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florian M. E.","family":"Wagenlehner","sequence":"additional","affiliation":[{"name":"Clinic for Urology, Paediatric Urology and Andrology, Justus-Liebig University of Giessen, Giessen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-013-1154-8"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.euus.2004.06.003"},{"key":"e_1_3_2_4_2","volume-title":"Rapid risk assessment: carbapenem-resistant Enterobacteriaceae\u2014first update","author":"European Centre for Disease Prevention and Control","year":"2018","unstructured":"European Centre for Disease Prevention and Control. 2018. Rapid risk assessment: carbapenem-resistant Enterobacteriaceae\u2014first update. ECDC, Stockholm, Sweden."},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1097\/MCC.0000000000000235"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-018-0278-9"},{"key":"e_1_3_2_7_2","unstructured":"EUCAST. 2019. The European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. Version 9.0 2019. http:\/\/www.eucast.org."},{"key":"e_1_3_2_8_2","volume-title":"Antimicrobial resistance surveillance in Europe 2015. Annual Report of the European Antimicrobial Resistance Surveillance Network (EARS-Net)","author":"European Centre for Disease Prevention and Control","year":"2017","unstructured":"European Centre for Disease Prevention and Control. 2017. Antimicrobial resistance surveillance in Europe 2015. Annual Report of the European Antimicrobial Resistance Surveillance Network (EARS-Net). ECDC, Stockholm, Sweden."},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2017.11.004"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1128\/cmr.1.1.54"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00886-10"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/2.3.271"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1159\/000239140"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1007\/bf01643430"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.40.8.1914"},{"key":"e_1_3_2_16_2","first-page":"1329","article-title":"Determination of dissolution of fosfomycin sodium by spectrophotometry with alizarin","volume":"4","author":"Liu YM","year":"2010","unstructured":"Liu YM, Guo JJ, Ma X, Xuan CS. 2010. Determination of dissolution of fosfomycin sodium by spectrophotometry with alizarin. Chin J Spectrosc Lab 4:1329\u20131331.","journal-title":"Chin J Spectrosc Lab"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/34.4.465"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00833-10"},{"key":"e_1_3_2_19_2","unstructured":"Fawzi MB Zhu T Shah SM. February 2011. Tigecycline compositions and methods of preparation. US patent 7879828."},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01192-06"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2019.07.018"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1086\/344653"},{"key":"e_1_3_2_23_2","volume-title":"Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard M07-A10","author":"Clinical and Laboratory Standards Institute","year":"2015","unstructured":"Clinical and Laboratory Standards Institute. 2015. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard M07-A10. CLSI, Wayne, PA."},{"key":"e_1_3_2_24_2","first-page":"1","article-title":"EUCAST Discussion Document E. Dis 5.1. Determination of minimum inhibitory concentrations (MICs) of antibacterial agents by broth dilution","volume":"9","author":"European Committee on Antimicrobial Susceptibility testing (EUCAST) of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID)","year":"2003","unstructured":"European Committee on Antimicrobial Susceptibility testing (EUCAST) of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID). 2003. EUCAST Discussion Document E. Dis 5.1. Determination of minimum inhibitory concentrations (MICs) of antibacterial agents by broth dilution. Clin Microbiol Infect 9:1\u20137.","journal-title":"Clin Microbiol Infect"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0076-6879(99)10037-5"},{"key":"e_1_3_2_26_2","first-page":"330","volume-title":"Antibiotics in laboratory medicine","author":"Eliopoulos GM","year":"1996","unstructured":"Eliopoulos GM, Moellering RC. Jr, 1996. Antimicrobial combinations, p 330\u2013396. In Lorian V (ed), Antibiotics in laboratory medicine, 4th ed. Williams & Wilkins, Baltimore, MD.","edition":"4"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkx441"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02446-16"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1128\/aac.48.2.521-524.2004"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkh205"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dku143"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.41.10.2256"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-199732020-00002"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01466-05"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2005.09.014"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.01839-19","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.01839-19","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T21:39:46Z","timestamp":1645479586000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.01839-19"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,20]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12,20]]}},"alternative-id":["10.1128\/AAC.01839-19"],"URL":"https:\/\/doi.org\/10.1128\/aac.01839-19","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,20]]},"assertion":[{"value":"2019-09-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-10-15","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-12-20","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e01839-19"}}